Navigation Links
Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Date:1/8/2009

tes from discovery into the clinic."

Principal investigator Osama Gaber, M.D., F.A.C.S. Director, Transplant Center of Excellence at The Methodist Hospital, Houston, Texas said, "Our clinical team is excited to participate in clinical trials that evaluate new therapies for renal transplant patients. Patients that develop DGF following renal transplantation have inferior kidney graft survival compared to those who do not. There is a real unmet medical need for a drug product to prevent DGF."

Daniel Zurr, Chief Executive Officer, commented, "We are very pleased to announce initiation of human dosing of the systemically administered QPI-1002 in our Phase I/II trial in kidney transplant patients. Furthermore, our siRNA drug candidate, PF-4523655, has been advanced into two Phase II clinical trials -- one for diabetic macular edema and the other for age related macular degeneration -- by our licensee, Pfizer. In addition, we recently announced that our QPI-1007 drug candidate, utilizing a novel siRNA structure developed by Quark, is being evaluated in advanced IND-enabling preclinical studies as a neuroprotective agent for eye diseases. These significant developments confirm the robustness of Quark's clinical pipeline and the strength of its capabilities in the RNAi arena."

Delayed graft function (DGF) is one of the most common complications during the immediate postoperative period in renal transplantation and affects 25-40% of the deceased donor renal transplants in the United States. DGF in renal transplantation results most often from ischemia-reperfusion injury that occurs when the blood flow is re-established to the transplanted kidney initiating a chain of events that can lead to severe renal damage upon transplantation. Post-kidney transplant DGF is associated with longer hospital stays and higher rates of graft rejection, which in turn decreases the survival of the transplanted kidney (graft survival). Current
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
2. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
3. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
4. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
5. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
6. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
7. Quark Pharmaceuticals Appoints New Chief Medical Officer
8. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
9. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2015 Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend of twelve cents per outstanding share, ... at the close of business on June 12, 2015. ... in 1906, Kewaunee Scientific Corporation is a recognized global ... healthcare, and technical furniture products. Products include steel, wood, ...
(Date:6/2/2015)... June 2, 2015  MGC Diagnostics Corporation (NASDAQ: ... today reported financial results for the second quarter ... second quarter domestic equipment, supplies and accessories revenues, ... at $4.2 million.  During the quarter, competitive account ... compared to 12 accounts, or $850,000 in revenue ...
(Date:6/2/2015)... June 2, 2015 REPORT HIGHLIGHTS ... nearly $3.7 billion in 2013. This market is expected to ... $7.8 billion in 2019, with compound annual growth rate (CAGR) ... This report provides: An in-depth analysis ... global market trends, with data from 2013, estimates for 2014, ...
Breaking Medicine Technology:MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 12MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 13MGC Diagnostics Corporation Reports Fiscal 2015 Second Quarter Results 14Global Markets and Technologies for Medical Lasers 2
...  Physicians at University Hospitals (UH) Case Medical ... global, multicenter, randomized clinical trial evaluating the safety and ... treatment of peripheral arterial disease (PAD).  ... Kashyap, MD, with UH Harrington-McLaughlin Heart & Vascular Institute ...
... 2012 Radient Pharmaceuticals Corporation (OTCQX:RXPC) (OTCPK:RXPC), ... (IVD) cancer tests, today announced that its ... Presentation for its Onko-Sure® cancer test kit ... http://radient-pharma.com/pdf/press_releases/2012/Radient%20Outreach%20Plan.pdf "Onko-Sure® is ...
Cached Medicine Technology:UH Case Medical Center the First in Region to Enroll Patients in Worldwide Study 2UH Case Medical Center the First in Region to Enroll Patients in Worldwide Study 3UH Case Medical Center the First in Region to Enroll Patients in Worldwide Study 4Radient Pharmaceuticals Introduces its 2012 Sales, Advertising & Outreach Plan Presentation 2Radient Pharmaceuticals Introduces its 2012 Sales, Advertising & Outreach Plan Presentation 3
(Date:6/2/2015)... June 02, 2015 MedPro Healthcare Staffing, ... to healthcare facilities, today announced the worldwide release of ... mobile tool to help candidates find best jobs that ... released in 2014, 9 in 10 job seekers report ... job search. , The MedPro Top Jobs app gives ...
(Date:6/2/2015)... IMPAK Corporation, a leading provider ... the availability of “child-resistant” pouches and gusseted bags ... especially curious toddlers. The Child Resistant packaging is ... CFR 1700.20 protocols. The announcement was made by ... Candy, “With the proliferation of consumer products that ...
(Date:6/2/2015)... 02, 2015 With a dedicated focus to ... Health Care has hired Leslie Young as director of ... resource initiatives to better understand and respond to the distinct ... 47 communities in 13 states across the country. , “As ... personalized support to our residents, we are making it an ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Though almost the ... refused to let the disease rule their lives. Organizing and ... their dedication to living life to the fullest and spreading ... careless about it, but I won't live my life in ... “The last thing you'd want is to look back on ...
(Date:6/2/2015)... Middletown, NY (PRWEB) June 02, 2015 ... Healthcare as a pioneering provider of value-based care ... or live in Orange and Sullivan Counties. The newly ... State approval for its commercial Small Group Preferred Provider ... , Crystal Run Healthcare’s Managing Partner and CEO, ...
Breaking Medicine News(10 mins):Health News:MedPro Healthcare Staffing Launches New MedPro Top Jobs App To Facilitate Job Search For Healthcare Professionals 2Health News:IMPAK Introduces Child Resistant Zip Pouches & Bags 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 2Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 3Health News:Tutera Senior Living & Health Care Hires HR Pro Leslie Young to Lead New Initiatives to Become Employer of Choice 4Health News:Family brings awareness to genetic disease at first Memphis walk 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 2Health News:Leading Health Care Innovator Poised to Deliver New Health Coverage Options To The Hudson Valley Region 3
... lead to new treatments for the disease, study suggests , , ... transplanting healthy liver cells into mice with hemophilia enables the ... with type A hemophilia. , The breakthrough finding may lead ... most common type of the disease, researchers believe. , "We ...
... ACTON, Mass., Feb. 14 Psychemedics,Corporation (Amex: ... for the period ended December 31, 2007, which included,record ... Company,also announced a quarterly dividend of $0.15 per share ... to be paid on March 21, 2008.,This will be ...
... to Underserved Populations, WASHINGTON, Feb. 14 ... public agencies and private,parties to work together to ... to vulnerable populations, particularly low-income children., In ... on Oversight and,Government Reform Subcommittee on Domestic Policy, ...
... Toronto Stock Exchange Symbol: CYT, MONTREAL, Feb. 14 ... products to treat cardiac,arrhythmias, today announced financial results for ... First Quarter Financial and Operational Highlights: - ... a strong 32.2% increase over ...
... 14 TeamStaff, Inc.,(Nasdaq: TSTF ), a national ... financial results for the first,quarter ended December 31, 2007., ... December 31, 2007 was,$0.1 million as compared to a ... Income from continuing operations was $0.04 million or,$0.00 per ...
... team up to ambush a critical tumor suppressor by evicting ... death by a protein-shredding mechanism, a team led by scientists ... reports in the Feb. 10 issue of Nature Cell Biology. ... of attack on FOXO3a, a member of the forkhead family ...
Cached Medicine News:Health News:Transplanted Liver Lining Cells May Cure Hemophilia 2Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 2Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 3Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 4Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 5Health News:Psychemedics Corporation Announces Year End Results Record Annual and Quarterly Revenue 6Health News:ADA Calls for All Stakeholders to Work Together to Help Medicaid 2Health News:CryoCath Announces Fiscal 2008 First Quarter Results 2Health News:CryoCath Announces Fiscal 2008 First Quarter Results 3Health News:CryoCath Announces Fiscal 2008 First Quarter Results 4Health News:CryoCath Announces Fiscal 2008 First Quarter Results 5Health News:CryoCath Announces Fiscal 2008 First Quarter Results 6Health News:CryoCath Announces Fiscal 2008 First Quarter Results 7Health News:CryoCath Announces Fiscal 2008 First Quarter Results 8Health News:CryoCath Announces Fiscal 2008 First Quarter Results 9Health News:CryoCath Announces Fiscal 2008 First Quarter Results 10Health News:CryoCath Announces Fiscal 2008 First Quarter Results 11Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 2Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 3Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 4Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 5Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 6Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 7Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 8Health News:TeamStaff Reports First Quarter Net Income and $0.7 Million Income Improvement From Continuing Operations Over Prior Year 9Health News:Oncoproteins double-team and destroy vital tumor-suppressor 2
Concave inner surface to conform to the globe. Used in conjunction with the E5381 600 Circling Band (40 style). Indications: Wide scleral bed. Outside diameter 30.2 mm....
...
...
...
Medicine Products: